Synthesis and nuclear factor-κB inhibitory activities of 6- or 7-methylchroman-2-carboxylic acid N-(substituted) phenylamides

Archives of Pharmacal Research

Volumn 32, Issue 2, 2009, Pages 167-175

  Kwak, Jae Hwan ^a   Won, Sun Woo ^a   Kim, Tae Jeong ^a   Yi, Wonhui ^a   Choi, Eun Hwa ^a   Kim, Seung Chan ^a   Park, Hyunjeong ^a   Roh, Eunmiri ^a   Jung, Jae Kyung ^a   Hwang, Bang Yeon ^a   Hong, Jin Tae ^a   Kim, Youngsoo ^a   Cho, Jungsook ^b   Lee, Heesoon ^a  

^a Chungbuk National University   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

Author keywords

6 Methylchroman 2 carboxamide; 7 Methylchroman 2 carboxamide; NF B inhibitor

Indexed keywords

6 METHYLCHROMAN 2 CARBOXYLIC ACID N (2 HYDROXYPHENYL)AMIDE; 6 METHYLCHROMAN 2 CARBOXYLIC ACID N (4 CHLOROPHENYL)AMIDE; 6 METHYLCHROMAN 2 CARBOXYLIC ACID PHENYLAMIDE DERIVATIVE; 7 METHYLCHROMAN 2 CARBOXYLIC ACID N (4 CHLOROPHENYL)AMIDE; 7 METHYLCHROMAN 2 CARBOXYLIC ACID N (4 METHOXYPHENYL)AMIDE; 7 METHYLCHROMAN 2 CARBOXYLIC ACID PHENYLAMIDE DERIVATIVE; ANILIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KL 1156; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; MOUSE; NONHUMAN; REACTION ANALYSIS; STRUCTURE ANALYSIS;

ANIMALS; CELL LINE; CHROMANS; INHIBITORY CONCENTRATION 50; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOLECULAR STRUCTURE; NF-KAPPA B; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 62449104035     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1131-3     Document Type: Article

References (19)

1. P. A. Baeuerle D. Baltimore 1996 NF-kB: Ten Years After Cell 87 13 20
2. A. S. Baldwin Jr. 1996 The NF-kappa B and I kappa B proteins: new discoveries and insights Annu. Rev. Immunol. 14 649 683
3. J. Dutta Y. Fan N. Gupta G. Fan C. Gelinas 2006 Current insights into the regulation of programmed cell death by NF-kB Oncogene 25 6800 6816
4. Hacker, H. and Karin, M., Regulation and function of IKK and IKK-related kinases. Sci. STKE, 2006, re13 (2006).
5. M. S. Hayden S. Ghosh 2004 Signaling to NF-kappaB Genes Dev. 18 2195 2224
6. A. Israel O. Le Bail D. Hatat J. Piette M. Kieran F. Logeat D. Wallach M. Fellous P. Kourilsky 1989 TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors EMBO J. 8 3793 3800
7. B. H. Kim A. M. Reddy K. H. Lee E. Y. Chung S. M. Cho H. Lee K. R. Min Y. Kim 2004 Inhibitory mechanism of chroman compound on LPS-induced nitric oxide production and nuclear factor-kappaB activation Biochem. Biophys. Res. Commun. 325 223 228
8. J. H. Kwak B. H. Kim J. K. Jung Y. Kim J. Cho H. Lee 2007 Structure-activity relationships of 6-hydroxy-7-methoxychroman-2-carboxylic acid N-(substituted)phenylamides as inhibitors of nuclear factor-kappaB activation Arch. Pharm. Res. 30 1210 1215
9. J. H. Kwak S. W. Won T. J. Kim E. Roh H. Y. Kang H. W. Lee J. K. Jung B. Y. Hwang Y. Kim J. Cho H. Lee 2008 Synthesis of chroman-2-carboxylic acid N-(substituted) phenylamides and their inhibitory effect on nuclear factor-kappaB (NF-kappaB) activation Arch. Pharm. Res. 31 133 141
10. S. S. Makarov 2000 NF-[kappa]B as a therapeutic target in chronic inflammation: recent advances Molecular Medicine Today 6 441 448
11. M. J. May S. Ghosh 1998 Signal transduction through NF-kB Immunol. Today 19 80 88
12. M. W. Mayo A. S. Baldwin 2000 The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance Biochim. Biophys. Acta 1470 M55 62
13. L. I. Mckay J. A. Cidlowski 1999 Molecular control of immune/inflammatory responses: interactions between nuclear factor-kB and steroid receptor-signaling pathways Endocr. Rev. 20 435 459
14. C. Michiels E. Minet D. Mottet M. Raes 2002 Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes Free Radic. Biol. Med. 33 1231 1242
15. L. Osborn S. Kunkel G. J. Nabel 1989 Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B Proc. Natl. Acad. Sci. USA 86 2336 2340
16. N. D. Perkins 2007 Integrating cell-signalling pathways with NF-kappaB and IKK function Nat. Rev. Mo . Cell. Biol. 8 49 62
17. B. Rayet C. Gelinas 1999 Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 6938 6947
18. R. Sen D. Baltimore 1986 Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism Cell 47 921 928
19. Y. Yamamoto R. B. Gaynor 2001 Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer J. Clin. Invest. 107 135 142